Answers are grounded in this paper and cite their sources.
• Label-free immunosensors enable personalized cancer treatments. • High sensitivity allows label-free sensors to detect cancer biomarkers. • Eliminating the need of expensive labels makes these sensors affordable. • Immunosensors can simultaneously detect multiple cancer biomarkers. • Real-time monitoring aids in disease management and treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Balu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: